Sight Sciences, Inc. SGHT
10.62 USD -0.15 (-1.39%)
Regular-session close
10.40 -0.22 -2.07%
After hours · Nov 19, 6:52 PM ET
10.31 Day range 10.88
3.38 52-week range 11.60
- YTD
- +33.92%
- 1 year
- +53.25%
Analyst view
Consensus: hold
Hold
Price target (mean) 5.02 -52.7% downside
Now 10.62
- Target (low)
- 4.00
- Target (mean)
- 5.02
- Target (high)
- 6.00
Ratings (0m) 7 1 buy · 6 hold · 0 sell
- Strong buy0
- Buy1
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
- 3 months ago 7
Included in Essentials and up
Sign in to see Revenue and earnings forecast
Reported revenue and earnings per share by year, then what analysts expect next.
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.18875 | -0.31 – -0.09376 | -0.22 | +14.2% | 20.29M | +8.2% | 5 |
| Next quarter | -0.19667 | -0.30 – -0.13 | -0.289 | +31.9% | 20.00M | +3.8% | 3 |
| Current year | -0.91235 | -0.95 – -0.88706 | -1.14 | +20.0% | 81.19M | +0.2% | 3 |
| Next year | -0.7098 | -1.07 – -0.55922 | -0.91235 | +22.2% | 87.81M | +8.1% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 11, 2024 | Citigroup | Maintained | Neutral | Neutral |
| Dec 6, 2024 | UBS | Initiated | — | Buy |
| Nov 11, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 8, 2024 | Piper Sandler | Reiterated | Neutral | Neutral |
| Nov 8, 2024 | Needham | Reiterated | — | Hold |
| Aug 21, 2024 | Lake Street | Initiated | — | Buy |
| Aug 2, 2024 | Needham | Reiterated | — | Hold |
| Jul 15, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 10, 2024 | Citigroup | Maintained | Neutral | Neutral |
| May 3, 2024 | Piper Sandler | Reiterated | Neutral | Neutral |
| May 3, 2024 | Needham | Reiterated | — | Hold |
| Apr 10, 2024 | Needham | Reiterated | — | Hold |
| Mar 8, 2024 | Stifel | Maintained | Buy | Buy |
| Dec 4, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 8, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Sep 18, 2023 | Stifel | Maintained | Buy | Buy |
| Sep 15, 2023 | Citigroup | Maintained | Neutral | Neutral |
| Sep 13, 2023 | B of A Securities | Downgrade | Neutral | Underperform |
| Sep 13, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Sep 12, 2023 | B of A Securities | Downgrade | Neutral | Underperform |
| Sep 12, 2023 | William Blair | Downgrade | Outperform | Market Perform |
| Sep 12, 2023 | Piper Sandler | Downgrade | Overweight | Neutral |
| Aug 24, 2023 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Aug 21, 2023 | Citigroup | Maintained | Neutral | Neutral |
| Aug 4, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 11, 2023 | Citigroup | Downgrade | Buy | Neutral |
| Jul 10, 2023 | Citigroup | Downgrade | Buy | Neutral |
| Jun 26, 2023 | Stifel | Maintained | Buy | Buy |
| Jun 12, 2023 | Needham | Maintained | — | Hold |
| Jun 6, 2023 | B of A Securities | Maintained | Buy | Buy |
Included in Plus and up
Sign in to see Analyst trend
Two years of the analyst rating mix and the average price target against the price.
